Therapeutic Asset Ratings

200 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Eovist Liver Cirrhosis	Massachusetts General Hospital		D (30)
Eovist Portal Hypertension	Massachusetts General Hospital		D (30)
Eovist PSC	Massachusetts General Hospital		D (30)
Gadobutrol Hepatic Cell Carcinoma	Massachusetts General Hospital	N/A	D (30)
Gadobutrol Portal Hypertension	Massachusetts General Hospital		D (30)
Tilmanocept Arteritis	Massachusetts General Hospital		D (30)
Tilmanocept Atherosclerosis	Massachusetts General Hospital		D (30)
Tilmanocept Atherosclerotic Cardiovascular Disease	Massachusetts General Hospital		D (30)
Tilmanocept Cardiovascular Disorder	Massachusetts General Hospital		D (30)
Tilmanocept Carotid Stenosis	Massachusetts General Hospital		D (30)
Tilmanocept Cerebrovascular Accident	Massachusetts General Hospital		D (30)
Tilmanocept Myocardial Infarction	Massachusetts General Hospital		D (30)
Tilmanocept Heart Disorder	Massachusetts General Hospital		D (30)
Tilmanocept Hyperlipidemia	Massachusetts General Hospital		D (30)
Tilmanocept Transient Ischemic Attack	Massachusetts General Hospital		D (30)
Tilmanocept Calcinosis	Massachusetts General Hospital		D (30)
Tilmanocept Peripheral Vascular Disease	Massachusetts General Hospital		D (30)
Tilmanocept Vascular Diseases	Massachusetts General Hospital		D (30)
Prevnar Chronic Lymphocytic Leukemia	Massachusetts General Hospital		D (28)
Tilmanocept Stroke Disorder	Massachusetts General Hospital		D (28)
gi-4000 Chronic Lymphocytic Leukemia	Massachusetts General Hospital		D (27)
Activated T Cells Multiple Myeloma	Massachusetts General Hospital		D (26)
gi-4000 Multiple Myeloma	Massachusetts General Hospital		D (25)
Ketorolac Tromethamine Chronic Opioid Use	Massachusetts General Hospital	P4	NR (0)
Ketorolac Tromethamine Injury	Massachusetts General Hospital	P4	NR (0)

Showing 176 to 200 of 200 assets

PreviousPage 8 of 8Next